mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |